SCYNEXIS Stock

SCYNEXIS Assets per Share

The Total Assets per Share of SCYNEXIS (SCYX) as of Sep 4, 2026 is 2.16 USD. In the previous year, Total Assets per Share was 3.06 USD — a change of -29.41% (lower).

Assets per Share

2.16USD

YoY

-29.41%

Last updated:

Total Assets per Share of SCYNEXIS is 2026 2.16 USD. Total Assets per Share of SCYNEXIS was 2025 3.06 USD. It decreases by -29.41% lower compared to the previous year.

The SCYNEXIS Assets per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Assets per Share
Date
Assets per Share
Jan 1, 2017
1.09 USD
Jan 1, 2018
1.27 USD
Jan 1, 2019
1.36 USD
Jan 1, 2020
2.44 USD
Jan 1, 2021
2.85 USD
Jan 1, 2022
2.09 USD
Jan 1, 2023
3.06 USD
Jan 1, 2024
2.16 USD
The SCYNEXIS Assets per Share history
YEARAssets per ShareYoY
2.16USD-29.41%
3.06USD+46.26%
2.09USD-26.71%
2.85USD+16.88%
2.44USD+79.20%
1.36USD+7.52%
1.27USD+15.90%
1.09USD-23.24%
1.42USD+21.30%
1.17USD+24.18%
0.95USD
Access this data via the Eulerpool API

SCYNEXIS Stock analysis

What does SCYNEXIS do? SCYNEXIS Inc is a biopharmaceutical company that focuses on the discovery and development of novel therapeutics for serious infectious diseases and cancer. The company was founded in 2000 and is headquartered in New Jersey, USA. SCYNEXIS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about SCYNEXIS stock

Total Assets per Share of SCYNEXIS is 2.16 USD in 2026.

Total Assets per Share of SCYNEXIS changed from 3.06 USD to 2.16 USD, representing a -29.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Total Assets per Share SCYNEXIS since 2006 – with annual values, charts, and detailed analysis.

Assets per share divides total assets by shares outstanding, indicating the total resource base backing each share of stock.

Access this data via the Eulerpool API

Other — SCYNEXIS

All Key Metrics — SCYNEXIS